Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-02

Clinical Trial Update: Pre Transplant Rapamycin Treatment in Islet Transplantation Alone [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on pre-transplant rapamycin treatment in islet transplantation for Type 1 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapamycin (sirolimus)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED